CRDF
CRDF clinical trials: Cardiff Oncology, Inc.
Every trial on ClinicalTrials.gov where Cardiff Oncology, Inc. is the lead sponsor or a listed collaborator, the trials it leads first, each labelled Lead or Collaborator. Phase, status and dates as registered.
- 12
- Trials linked
- 7
- As lead sponsor
- 5
- As collaborator
- 0
- Primary completions as lead sponsor, next 90 days
CRDF on the catalyst calendar · CRDF registry changes
- Primary completion Apr 16, 2027Sponsor estimatePhase 2NCT06106308Study of Onvansertib in Combination With FOLFIRI and Bevacizumab or FOLFOX and Bevacizumab Versus FOLFIRI and Bevacizumab or FOLFOX and...Cardiff Oncology · Metastatic Colorectal CancerActive, not recruitingCRDFLeadPFECollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 24, 2024ActualPhase 2NCT04752696Onvansertib in Combination With Nanoliposomal Irinotecan, Leucovorin, and Fluorouracil for Second-Line Treatment of Participants With...Cardiff Oncology · Pancreatic Ductal AdenocarcinomaTerminatedCRDFLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jan 29, 2024ActualPhase 1/Phase 2NCT03829410Onvansertib in Combination With FOLFIRI and Bevacizumab for Second Line Treatment of Metastatic Colorectal Cancer Patients With a KRAS...Cardiff Oncology · Metastatic Colorectal CancerCompletedCRDFLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 9, 2024ActualPhase 2NCT05593328Study of Onvansertib in Combination With FOLFIRI and Bevacizumab Versus FOLFIRI and Bevacizumab for Second Line Treatment of Metastatic...Cardiff Oncology · Colorectal CancerCompletedCRDFLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Oct 16, 2023ActualPhase 2NCT03414034Onvansertib in Combination With Abiraterone and Prednisone in Adult Patients With Metastatic Castration-Resistant Prostate CancerCardiff Oncology · Metastatic Castration-Resistant Prostate CancerCompletedCRDFLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Not registeredNo phase registeredNCT04446793Expanded Access of Onvansertib With FOLFIRI and Bevacizumab for the Second-Line Treatment of Participants With KRAS-Mutated Metastatic...Cardiff Oncology · Metastatic Colorectal CancerNo longer availableCRDFLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Nov 17, 2021ActualPhase 1/Phase 2NCT03303339Onvansertib in Combination With Either Low-dose Cytarabine or Decitabine in Adult Patients With Acute Myeloid Leukemia (AML)Cardiff Oncology · Acute Myeloid LeukemiaCompletedCRDFLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 15, 2026Sponsor estimatePhase 1/Phase 2NCT05383196Onvansertib + Paclitaxel In TNBCAntonio Giordano, MD · Breast CancerActive, not recruitingCRDFCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jul 16, 2026ActualPhase 1/Phase 2NCT06736717Onvansertib in Combination With NALIRIFOX for First Line Treatment of Advanced Pancreatic CancerUniversity of Kansas Medical Center · Pancreatic CancerActive, not recruitingCRDFCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jun 1, 2027Sponsor estimateEarly Phase 1NCT04005690Targeted Pathway Inhibition in Patients With Pancreatic CancerOHSU Knight Cancer Institute · Locally Advanced Pancreatic Ductal AdenocarcinomaRecruitingCRDFCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Aug 31, 2027Sponsor estimatePhase 2NCT05450965Study of PLK1 Inhibitor, Onvansertib, in Relapsed Small Cell Lung CancerUniversity of Maryland, Baltimore · Small-cell Lung CancerRecruitingCRDFCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Sep 2016ActualNo phase registeredNCT02186236Detection of Oncogenic Tumor Mutations in the Urine and Blood of Lung and Colorectal Cancer PatientsMemorial Sloan Kettering Cancer Center · Lung CancerCompletedCRDFCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
Enrollment, interventions and the start and completion dates are locked on 12 rows here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.
Unlock with TrialScanner